The Relationship among Splenomegaly, Lung Involvement Patterns, and Severity Score in COVID-19 Pneumonia

Article ID: e090522204492 Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Introduction: The disease caused by the novel coronavirus (COVID -19) is a vital public health problem that has now affected approximately 68,037,473 people and caused 1,552,802 deaths around the world. We aimed to correlate the frequency of the lung involvement patterns, the segmental distribution of lung infiltration, and TLSS in COVID-19 pneumonia patients with and without splenomegaly.

Material and Methods: This retrospective study included patients admitted to Yunus Emre State Hospital Emergency, Internal Medicine and Infectious Disease Departments between March 11, 2020, and June 10, 2020, and diagnosed with COVID-19 by PCR test with a throat and nasal swab. The thoracic and upper abdomen CTs and the clinical and demographic features of the patients were analyzed at the time of initial diagnosis.

Results: Consolidation (group 1 - 18 (47%), group 2 - 69 (28.2%); P = 0017), crazy pavement pattern (15 (39.5%), 42 (17.1%); p = 0.001), pleural band formations (24 (63.2%), 87 (35.5%); p = 0.001), interlobular septal thickening (23 (60.5%), 79 (32.2%); p = 0.001), and sequelae of secondary tuberculosis (4 (10.5%), 8 (3.3%); p = 0.039) were more frequent in the patient with splemomegaly. The total lung severity score was high in the group with splenomegaly (7.32 ± 6.15, 3.69 ± 5.16; p = 0.001).

Conclusion:Consolidation, interlobular septal thickening, tuberculosis sequela, pleural band, and crazy pavement patterns were frequent in the COVID-19 pneumonia patients with splenomegaly. The most frequently affected segment was the superior segment of the right lower lobe. TLSS was higher in the COVID-19 pneumonia patients with splenomegaly.

Keywords: Total lung severity score, COVID-19 pneumonia, splenomegaly, lung infiltration patterns, consolidation, GGO.

Graphical Abstract

[1]
Coronavirus Outbreak. Available from: https://www.worldometers.info/coronavirus/ [Accessed on 08 Dec 2020].
[2]
Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020; 87(4): 281-6.
[http://dx.doi.org/10.1007/s12098-020-03263-6] [PMID: 32166607]
[3]
Varım C, Demirci T, Cengiz H, et al. Relationship between serum osteopontin levels and the severity of COVID-19 infection. Wien Klin Wochenschr 2020; 28: 1-5.
[PMID: 33369698]
[4]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[5]
Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020; 35(5): 1545-9.
[http://dx.doi.org/10.1007/s11606-020-05762-w] [PMID: 32133578]
[6]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[7]
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061-9.
[http://dx.doi.org/10.1001/jama.2020.1585] [PMID: 32031570]
[8]
Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A retrospective analysis. Respir Res 2020; 21(1): 74.
[http://dx.doi.org/10.1186/s12931-020-01338-8] [PMID: 32216803]
[9]
Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020; 3: 270.
[10]
Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv 2020.
[11]
Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): A study of 63 patients in Wuhan, China. Eur Radiol 2020; 30(6): 3306-9.
[http://dx.doi.org/10.1007/s00330-020-06731-x] [PMID: 32055945]
[12]
Plesner LL, Dyrberg E, Hansen IV, Abild A, Andersen MB. Diagnostic imaging findings in COVID-19. Ugeskr Laeger 2020; 182(15): V03200191.
[PMID: 32286216]
[13]
Shi H, Han X, Zheng C. Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China. Radiology 2020; 295(1): 20.
[http://dx.doi.org/10.1148/radiol.2020200269] [PMID: 32032497]
[14]
Li X, Zeng W, Li X, et al. CT imaging changes of corona virus disease 2019(COVID-19): A multi-center study in Southwest China. J Transl Med 2020; 18(1): 154.
[http://dx.doi.org/10.1186/s12967-020-02324-w] [PMID: 32252784]
[15]
Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease 2019 (COVID-19). Relationship to Duration of Infection Radiology 2020; 295: 200463.
[PMID: 32077789]
[16]
Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology 2020; 295(3)
[17]
Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020; 295(1): 210-7.
[http://dx.doi.org/10.1148/radiol.2020200274] [PMID: 32027573]
[18]
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect Dis 2020; 20(4): 425-34.
[http://dx.doi.org/10.1016/S1473-3099(20)30086-4] [PMID: 32105637]
[19]
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295(1): 202-7.
[http://dx.doi.org/10.1148/radiol.2020200230] [PMID: 32017661]
[20]
Wang C, Shi B, Wei C, Ding H, Gu J, Dong J. Initial CT features and dynamic evolution of early-stage patients with COVID-19. Radiol Infect Dis 2020; 7(4): 195-203.
[http://dx.doi.org/10.1016/j.jrid.2020.08.002] [PMID: 32864406]
[21]
Li L, Yang L, Gui S, et al. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China. Theranostics 2020; 10(14): 6113-21.
[http://dx.doi.org/10.7150/thno.46569] [PMID: 32483442]
[22]
Yang S, Shi Y, Lu H, et al. Clinical and CT features of early stage patients with COVID-19: A retrospective analysis of imported cases in Shanghai, China. Eur Respir J 2020; 55(4): 2000407.
[http://dx.doi.org/10.1183/13993003.00407-2020] [PMID: 32217649]
[23]
Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020; 47(5): 1275-80.
[http://dx.doi.org/10.1007/s00259-020-04735-9] [PMID: 32107577]
[24]
Cure E, Cure MC. COVID-19 may predispose to thrombosis by affecting both vascular endothelium and platelets. Clin Appl Thromb Hemost 2020; 26: 1076029620933945.
[http://dx.doi.org/10.1177/1076029620933945] [PMID: 32619104]
[25]
Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19. Thromb Haemost 2020; 120(12): 1629-41.
[http://dx.doi.org/10.1055/s-0040-1718735] [PMID: 33124029]
[26]
de Almeida Lima AN, Santos Leite Pessoa M, Franco Costa Lima C, Picasso de Araújo Coimbra P, Bezerra Holanda JL. Images in vascular medicine: Acute peripheral artery occlusion and ischemic stroke in a patient with COVID-19. Vasc Med 2020; 25(5): 482-3.
[http://dx.doi.org/10.1177/1358863X20945020] [PMID: 32812518]
[27]
Yang R, Li X, Liu H, et al. Chest CT Severity score: An imaging tool for assessing severe COVID-19 radiol. Radiol Cardiothorac Imaging 2020; 2(2): 2.
[http://dx.doi.org/10.1148/ryct.2020200047]
[28]
Zhang B, Zhang J, Chen H, et al. Novel coronavirus disease 2019 (COVID-19): Relationship between chest CT scores and laboratory parameters. Eur J Nucl Med Mol Imaging 2020; 47(9): 2083-9.
[http://dx.doi.org/10.1007/s00259-020-04854-3] [PMID: 32399620]
[29]
Tahtabasi M, Hosbul T, Karaman E, Akin Y, Konukoglu O, Sahiner F. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis. Clin Imaging 2021; 79: 104-9.
[http://dx.doi.org/10.1016/j.clinimag.2021.04.035] [PMID: 33932872]
[30]
Batur A, Kılınçer A, Ateş F, Aktuğ Demir N, Ergün R. Evaluation of systemic involvement of Coronavirus disease 2019 through spleen; size and texture analysis. Turk J Med Sci 2021; 51(3): 972-80.
[http://dx.doi.org/10.3906/sag-2009-270] [PMID: 33421971]
[31]
Prentice G, Wilson S, Coupland A, Bicknell S. Complete splenic infarction in association with COVID-19. BMJ Case Rep 2021; 14(12): e246274.
[http://dx.doi.org/10.1136/bcr-2021-246274] [PMID: 34876448]